文献速递甲状腺与浅表介入US

射频消融治疗良性甲状腺结节的疗效与安全性:一项前瞻性多中心研究

Efficacy and Safety of Radiofrequency Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study.
PubMed 文献 · Korean J Radiol · 2018-01-02

这项前瞻性多中心研究纳入345例良性甲状腺结节患者(345个结节),由经过培训的放射科医生按统一方案行射频消融。12个月平均体积缩小80.3%,治疗成功率97.8%,症状与美容评分均显著改善(p<0.001),主要并发症发生率1.0%(3/276)。实性与施加能量是体积缩小的独立预测因素。

要点

  • 12个月平均体积缩小80.3%,治疗成功率97.8%,主要并发症发生率1.0%(3/276)。
  • 症状评分与美容评分均较术前显著改善(p<0.001)。
  • 实性与施加能量是体积缩小的独立预测因素。

核心结论

  • 经过培训的放射科医生在多机构采用统一方案和相似设备行射频消融,对良性甲状腺结节有效且安全。

研究设计与样本

  • 前瞻性多中心研究,2010至2011年自五家机构纳入345例患者的345个结节(男:女=43:302,平均年龄46.0±12.7岁,范围15-79岁),术前平均体积14.2±13.2 mL(1.1-80.8 mL)。

关键影像表现/征象

  • 随访12个月及以上的276个病灶包括248个实性结节和28个以囊性为主的结节。
  • 所有操作者均使用冷循环射频系统,采用经峡部入路与移动消融技术两种标准技术。

诊断标准与关键数值

  • 12个月平均体积缩小80.3%(n=276),24、36、48、60个月随访分别为84.3%(n=198)、89.2%(n=128)、91.9%(n=57)、95.3%(n=6)。
  • 治疗成功率为97.8%。
  • 主要并发症发生率为1.0%(3/276)。
  • 实性与施加能量是预测体积缩小的独立因素。

临床应用与阅片要点

  • 由经过培训的放射科医生按统一方案、使用相似设备行射频消融,可作为良性甲状腺结节的治疗选择。
  • 术后12个月平均体积缩小80.3%,长期随访体积缩小进一步增加。
  • 主要并发症发生率为1.0%(3/276),症状与美容评分均显著改善(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the efficacy and safety of thyroid radiofrequency (RF) ablation for benign thyroid nodules by trained radiologists according to a unified protocol in a multi-center study.

MATERIALS AND METHODS: From 2010 to 2011, 345 nodules from 345 patients (M:F = 43:302; mean age ± SD = 46.0 ± 12.7 years, range = 15-79) who met eligibility criteria were enrolled from five institutions. At pre-ablation, the mean volume was 14.2 ± 13.2 mL (1.1-80.8 mL). For 12 months or longer after treatment, 276 lesions, consisting of 248 solid and 28 predominantly cystic nodules, were followed. All operators performed RF ablation with a cool-tip RF system and two standard techniques (a transisthmic approach and the moving-shot technique). Volume reduction at 12 months after RF ablation (the primary outcome), therapeutic success, improvement of symptoms as well as of cosmetic problems, and complications were evaluated. Multiple linear regression analysis was applied to identify factors that were independently predictive of volume reduction.

RESULTS: The mean volume reduction at 12 months was 80.3% (n = 276) and at the 24-, 36-, 48-, and 60-month follow-ups 84.3% (n = 198), 89.2% (n = 128), 91.9% (n = 57), and 95.3% (n = 6), respectively. Our therapeutic success was 97.8%. Both mean symptom and cosmetic scores showed significant improvements (p < 0.001). The rate of major complications was 1.0% (3/276). Solidity and applied energy were independent factors that predicted volume reduction.

CONCLUSION: Radiofrequency ablation performed by trained radiologists from multiple institutions using a unified protocol and similar devices was effective and safe for treating benign thyroid nodules.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Jung SL, Baek JH, Lee JH, et al. Efficacy and Safety of Radiofrequency Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study. Korean J Radiol. 2018. PMID: 29354014. doi:10.3348/kjr.2018.19.1.167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。